University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 13 of 21
Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
NCT02489123
Auto Control of Volume Management for Limb Loss
NCT03550118
WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
NCT02508246
Home Air in Agriculture: Pediatric Intervention Trial
NCT04919915
An SRT Model for Early Access to ASD Intervention
NCT02409303
Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety
NCT02497755
Clinical Trial NuSmile Crowns
NCT04975321
MS Symptom Management Study
NCT02474940
Parent Training and Emotion Coaching for Children With Limited Prosocial Emotions
NCT02409992
A Primary Prevention Trial to Strengthen Child Attachment in a Native Community
NCT02139332
Prehospital Tranexamic Acid Use for Traumatic Brain Injury
NCT01990768
Evaluation of a Modified Running-specific Prosthetic Foot
NCT02440711
Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project
NCT02438280
Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy
NCT02355886
Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers
NCT02401321
Understanding Non-Response in Spine Fusion Surgery
NCT02611479
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
NCT02432170
Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer
NCT02339870
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
NCT02358343
Brief Restructuring Intervention Following Trauma Exposure
NCT02808468
Yappalli - The Road to Choctaw Health
NCT02400554
Demand-driven Management of Essential Tremor
NCT02443181
Effect of Commute Traffic on Vascular Function
NCT05454930
Physical Therapists - Recommending EnhanceFitness to Expand Reach
NCT03139461
CNS Uptake of Intranasal Glutathione
NCT02324426
Feasibility of Telephone Counseling to Increase Physical Fitness in SCI
NCT02225028
Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT02227199
Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
NCT02207062
Proton Beam Re-Irradiation in Thoracic Cancers
NCT02204761
Beginning Relationships in a Native Community
NCT02091804
Dual Energy CT Urography With Reduced Iodinated Contrast
NCT02283307
Chest Ultrasound of ER Patients With Cough or SOB
NCT02269761
Mask Ventilation Before and After Neuromuscular Blockade
NCT02237443
RA-2 13-cis Retinoic Acid (Isotretinoin)
NCT02061384
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
NCT02137044
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
NCT02121418
CYP3A4 Activity and Mineral Homeostasis
NCT02019875
Structured Treatment of Pain (STOP) Study
NCT01768650
Improving the Concentration of MR Contrast in the Arteries
NCT02155218
Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery
NCT01816035
Enhance Wellness for Individuals With Long-Term Physical Disabilities
NCT02815878
Comparing Engage to PST for Late Life Depression
NCT02086201
Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA
NCT02160535
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
NCT02129049
A Comparative Effectiveness Trial of Optimal Patient-Centered Care
NCT02274688
Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma
NCT01970527
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
NCT01992861
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
NCT01922921
Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women
NCT02005510
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
NCT01982123
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.